Cargando…
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma
Diffuse intrinsic pontine glioma (DIPG) is a universally fatal childhood cancer of the brain. Despite the introduction of conventional chemotherapy and radiotherapy, improvements in survival have been marginal and long-term survivorship is uncommon. Thus, new targets for therapeutics are critically...
Autores principales: | Berlow, Noah E., Svalina, Matthew N., Quist, Michael J., Settelmeyer, Teagan P., Zherebitskiy, Viktor, Kogiso, Mari, Qi, Lin, Du, Yuchen, Hawkins, Cynthia E., Hulleman, Esther, Li, Xiao-Nan, Gultekin, Sakir H., Keller, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886401/ https://www.ncbi.nlm.nih.gov/pubmed/29621254 http://dx.doi.org/10.1371/journal.pone.0193565 |
Ejemplares similares
-
Receptor-driven invasion profiles in diffuse intrinsic pontine glioma
por: Karki, Anju, et al.
Publicado: (2021) -
Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma: A Report of the Children’s Oncology Group DIPG Preclinical Consortium
por: Grasso, Catherine S., et al.
Publicado: (2015) -
Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma
por: Lian, Xiaolei, et al.
Publicado: (2021) -
Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma
por: Lian, Xiaolei, et al.
Publicado: (2021) -
Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma
por: Buczkowicz, Pawel, et al.
Publicado: (2015)